Ledger.Open graph →

SEC Form D · filed February 23, 2022

Revelar Biotherapeutics, Inc

Offering

$1.0M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BETHESDA, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Glenn Marina · Bethesda, MDExec · Director Paul Fonteyne · Bethesda, MDDirector Brett Giroir · Bethesda, MDDirector Laurence Smith · Bethesda, MDExec David Scheer · New Haven, CTDirector Sal Guy · Henderson, NVExec Luyu Yang · BELLEVUE, WADirector Sumita Pennathur · Goleta, CADirector Rahima H. Blaza · Tempe, AZExec · Director Oliver Holle · Vienna, C4Director Youngme Moon · Brooklyn, NYDirector Jason Witherspoon · Groesbeck, TXExec Daniel S. Short · San Francisco, CAExec · Director Hannah S. Dunn · San Francisco, CADirector Joshua S. Dapice · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗